Бегущая строка

IBND $28.46 -0.6285%
BA.L $988.00 0.611%
CIE.MC $27.90 -0.2859%
CRWS $5.12 -0.9671%
VIV.PA $9.72 -0.3485%
XDWH.L $49.25 0.1831%
3658.HK $1.63 0%
0809.HK $0.13 5%
OSG $3.93 0.3836%
8462.HK $0.05 0%
BDN $3.56 -5.0667%
PAEJ.PA $15.65 -0.439%
GSAT $1.00 -1.9608%
0760.HK $0.02 0%
0KAB.L $956.62 0.4663%
BFZ $11.83 -0.2194%
0679.HK $0.88 -1.1236%
CAPD.L $95.80 0.8421%
VDF3.L $0.77 0%
ISAG.L $46.20 0.1083%
QULL $23.99 0%
AATC $4.00 0%
PAVM $0.52 0.9315%
ZGYHW $0.62 0%
ALCOG.PA $12.02 0.5017%
6998.HK $1.86 1.6393%
PEB.L $7.72 -3.5%
8101.HK $0.24 0%
TWND $9.80 0%
J69U.SI $2.22 0%
ALPDX.PA $13.15 -1.1278%
ECNS $31.44 -3.2615%
ALPIX.PA $0.05 -5.1878%
PXS.L $0.73 0%
GPJA $24.27 -0.1119%
GIGB $45.39 -0.4096%
CCEP $65.10 -1.2439%
0525.HK $2.03 -1.9324%
AGNCN $24.53 -0.4263%
ESPJ.L $41.71 -4.84772%
BHK $10.60 -2.1725%
0YXG.L $625.95 0.3704%
RJF.MC $2.57 0.3906%
0QN7.L $452.00 -1.3108%
SAGE $51.36 -2.3484%
EWI $31.28 -0.0639%
M14.SI $0.45 -1.0989%
SBEM.L $682.00 0.7014%
SOS $3.72 -2.6178%
CMDY $49.65 0.0909%
LRN $41.82 -0.6887%
0512.HK $5.00 -2.9126%
PVH $83.11 0.2896%
A5G.IR $3.89 2.2632%
GRBK $49.93 -2.2514%
WTAN.L $228.00 -0.2188%
VIRC $3.78 0%
0KV3.L $15.55 -2.0355%
0995.HK $8.52 1.0676%
TRMR $5.30 -4.3321%
MACAU $10.25 0%
ETJ $7.89 -0.0634%
DSM.L $65.25 0%
KZG.L $0.98 0%
CLWD.L $6.54 0%
SMAR $41.67 1.5846%
2310.HK $0.09 1.17647%
JBHT $176.05 -0.1645%
HWCC $5.30 0%
GYLD $12.44 -0.3021%
ATHX $0.82 1.9467%
BEST $2.85 -2.3973%
POWRU $10.16 0%
GLD $187.15 0.0107%
0HH6.L $1.01 -4.6363%
8003.HK $0.45 -1.1111%
DRUA $25.09 0%
LCAHU $10.11 0%
1643.HK $0.48 2.1277%
FUNC $12.89 -0.6091%
FNCL $43.59 -0.9543%
CMRS.L $5.00 0%
HJLI $10.38 0%
0QZU.L $346.49 -0.2533%
SPB $69.74 -2.2428%
8160.HK $0.07 15.5172%
0769.HK $0.46 -2.1505%
PRLH $10.49 0.0954%
JOBY $4.65 -2.0042%
SPSC.L $150.00 0%
SCAR3.SA $18.00 2.2727%
CARA $3.97 -1.6129%
SSIC $8.61 1.0569%
CGO.L $5.47 1.2963%
ATRY.MC $4.99 1.217%
HYUP $39.02 -0.2786%
SXLY.L $43.00 0.3325%
AVAN $10.04 0%
SCRMW $0.16 -11.8136%
ASAX $10.08 0%

Хлебные крошки

Акции внутренные

Лого

IDEXX Laboratories, Inc. IDXX

$482.54

-$4.15 (-0.86%)
На 18:00, 12 мая 2023

-3.70%

Потенциал через год

Ранг: 1

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    40098716512.00000000

  • week52high

    515.79

  • week52low

    317.06

  • Revenue

    3367324000

  • P/E TTM

    58

  • Beta

    1.19377100

  • EPS

    7.85000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    31 июл 2023 г. в 12:30

Описание компании

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.

Рекомендации аналитиков

Grading company New grade Previous grade Recommendation date
Barclays Overweight Overweight 05 авг 2022 г.
Morgan Stanley Overweight Overweight 04 авг 2022 г.
Atlantic Equities Overweight Overweight 03 авг 2022 г.
Piper Sandler Overweight Overweight 26 июл 2022 г.
Stifel Hold Buy 25 июл 2022 г.
JP Morgan Overweight Overweight 17 окт 2022 г.
Atlantic Equities Overweight Overweight 02 ноя 2022 г.
Morgan Stanley Overweight Overweight 15 ноя 2022 г.
Goldman Sachs Buy Buy 25 янв 2023 г.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

Новостная лента

  • Изображение

    IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day

    Business Wire

    10 мая 2023 г. в 09:15

    WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:15 pm (EDT). Individuals can access the live audio webcast of the presentation through a link on the IDEXX website, www.idexx.

  • Изображение

    3 Best Stocks to Buy in May and Hold Forever

    The Motley Fool

    10 мая 2023 г. в 07:45

    Teladoc looks to transition from a high-flying growth story to a profitable enterprise. Doximity's early profitability and cash generation point to incredible potential ahead.

  • Изображение

    IDEXX (IDXX) Q1 Earnings Beat Estimates, Margins Increase

    Zacks Investment Research

    02 мая 2023 г. в 13:43

    Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.

  • Изображение

    IDEXX Laboratories, Inc. (IDXX) Q1 2023 Earnings Call Transcript

    Seeking Alpha

    02 мая 2023 г. в 12:32

    IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Executive Vice President, Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Christopher Schott - JPMorgan Jonathan Block - Stifel Michael Ryskin - Bank of America Jack Senft - William Blair Erin Wright - Morgan Stanley David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.

  • Изображение

    Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

    Zacks Investment Research

    02 мая 2023 г. в 12:11

    The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.



Insider Summary

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
JUNIUS DANIEL M A 2982 14 30 янв 2023 г.
AYERS JONATHAN W D 168020 2400 14 дек 2022 г.
JUNIUS DANIEL M D 0 3046 05 дек 2022 г.
JUNIUS DANIEL M D 2968 3046 05 дек 2022 г.
JUNIUS DANIEL M A 6014 3046 05 дек 2022 г.
SZOSTAK M ANNE D 1046 2000 02 дек 2022 г.
SZOSTAK M ANNE D 1260 740 02 дек 2022 г.
SZOSTAK M ANNE A 2000 2000 02 дек 2022 г.
Turner Kathy V D 7386 3000 01 дек 2022 г.
Turner Kathy V D 6923 3000 01 дек 2022 г.